BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+21%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.84B
AUM Growth
+$2.84B
(+12%)
Cap. Flow
-$65.1M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
74.16%
Holding
31
New
1
Increased
10
Reduced
3
Closed
2
Top Buys
| 1 |
MacroGenics
MGNX
|
$28M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$16.1M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$15.1M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14.5M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$9.91M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$120M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$18M |
| 3 |
CELG
Celgene Corp
CELG
|
$15.7M |
| 4 |
Puma Biotechnology
PBYI
|
$12.7M |
| 5 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$5.88M |
Sector Composition
| 1 | Healthcare | 88.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.5B
| $366M | 12.86% |
3,879,822
+39,416
| +1% | +$3.72M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $362M | 12.71% |
3,459,298
-150,000
| -4% | -$15.7M |
|
3
Ionis Pharmaceuticals
IONS
$6.79B
| $262M | 9.23% |
7,163,172
+58,334
| +0.8% | +$2.14M |
|
|
RDUS
4
DELISTED
Radius Health, Inc.
RDUS
| $236M | 8.29% |
4,360,399
| – | – |
|
5
Gilead Sciences
GILD
$140B
| $220M | 7.72% |
2,774,596
| – | – |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $158M | 5.56% |
3,121,552
| – | – |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $145M | 5.08% |
1,179,428
| – | – |
|
|
8
Agios Pharmaceuticals
AGIO
$2.19B
| $140M | 4.92% |
2,649,528
+286,207
| +12% | +$15.1M |
|
9
Vertex Pharmaceuticals
VRTX
$100B
| $123M | 4.34% |
1,415,445
| – | – |
|
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $98.5M | 3.46% |
245,000
+40,000
| +20% | +$16.1M |
|
|
TSRO
11
DELISTED
TESARO, Inc.
TSRO
| $97.7M | 3.43% |
974,582
-180,000
| -16% | -$18M |
|
12
Halozyme
HALO
$8.56B
| $89.1M | 3.13% |
7,379,832
| – | – |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $80.7M | 2.84% |
1,191,338
| – | – |
|
|
ALDR
14
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $55.2M | 1.94% |
1,685,150
| – | – |
|
|
CEMP
15
DELISTED
Cempra, Inc.
CEMP
| $49.4M | 1.74% |
2,041,900
| – | – |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $47.1M | 1.66% |
1,022,439
+171,800
| +20% | +$7.91M |
|
|
KITE
17
DELISTED
Kite Pharma, Inc.
KITE
| $44.7M | 1.57% |
800,000
+50,000
| +7% | +$2.79M |
|
|
18
MacroGenics
MGNX
$112M
| $43.5M | 1.53% |
1,455,000
+935,000
| +180% | +$28M |
|
|
JUNO
19
DELISTED
Juno Therapeutics, Inc.
JUNO
| $42.2M | 1.48% |
1,405,000
+100,000
| +8% | +$3M |
|
|
ICPT
20
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $42.1M | 1.48% |
255,719
| – | – |
|
21
Prothena Corp
PRTA
$441M
| $21M | 0.74% |
350,000
| – | – |
|
|
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $20.6M | 0.72% |
1,350,000
+650,000
| +93% | +$9.91M |
|
23
Esperion Therapeutics
ESPR
$448M
| $18.1M | 0.64% |
1,308,542
+300,000
| +30% | +$4.15M |
|
24
Novavax
NVAX
$1.21B
| $17.3M | 0.61% |
8,330,000
| – | – |
|
25
PTC Therapeutics
PTCT
$3.92B
| $16.6M | 0.58% |
1,182,912
| – | – |
|